LILY34
Eli Lilly & Co Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh · BMFBOVESPA:LILY34
257.00 BRL9.77 +3.95%
Eli Lilly & Co Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh (BMFBOVESPA:LILY34) last traded at 257.00 BRL, up 3.95% on the day. Over the past year the stock is up 69.64%. Its 52-week range is 142.00 to 262.80. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open255.32
Day range254.21 – 262.80
52-week range142.00 – 262.80
Volume32.01 K
Average volume (10 days)54.53 K
Market cap (USD)1.33 T
P/E4,151.86
EPS (TTM) (USD)0.0119
Dividend yield0.31%
Beta (1 year)−0.6523
Revenue (TTM) (USD)86.59 B
Employees50.00 K
Performance
+16.13%1 week
+24.36%1 month
+33.58%3 months
+69.03%6 months
+30.65%Year to date
+69.64%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Eli Lilly Is Maintained at Overweight by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
- Cantor Fitzgerald maintains Eli Lilly at Overweight, raises price target to $1600 from $1440TradingView · 02 Nov 2026
- Cathie Wood's weekly recap: loads TER, AVAV after strong results; books gain in AMD, TSM, LLYSeeking Alpha · 02 Nov 2026
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.